Abstract Number: 1425 • 2012 ACR/ARHP Annual Meeting
Circulating Free Protein S Levels May Be Linked to Cardiovascular Events and Venous Thrombosis in SLE
Background/Purpose: SLE patients are at risk for diverse organ systems involvement, which increases the challenges for diagnosis and predictions for the development of specific clinical…Abstract Number: 1426 • 2012 ACR/ARHP Annual Meeting
The Clinical Relevance of a “False Negative” Enzyme Linked Immunoassay: Which Antinuclear Antibody Screening Test Is Preferred by Rheumatologists in an Integrated Health System?
Background/Purpose: Historically, Immunofluorescence Assay (IFA) methodology has been the gold standard for ANA screening. Most clinical laboratories in recent years utilize the Enzyme Linked Immunoassay…Abstract Number: 1427 • 2012 ACR/ARHP Annual Meeting
Late Onset Systemic Lupus Erythematosus: Is It Actually A Milder Variant?
Background/Purpose: Classically, late onset Systemic Lupus Erythematosus (SLE) has been described as a milder variant of the disease. The objective of this study is to…Abstract Number: 1428 • 2012 ACR/ARHP Annual Meeting
Long-Term Outcomes of Children Born to Women with Systemic Lupus Erythematosus
Background/Purpose: SLE can cause considerable morbidity during pregnancy. Although several studies have evaluated foetal outcome in lupus pregnancy, very few have examined the long-term outcome…Abstract Number: 1429 • 2012 ACR/ARHP Annual Meeting
Women with Systemic Lupus Erythematosus (SLE) May Have Different Predictors of Risk for Progression of Aorta Calcium (AS) Than Women without SLE
Background/Purpose: Women with SLE have increased rates of subclinical atherosclerosis and cardiovascular (CV) events. We investigated which risk factors may be significant in the rate…Abstract Number: 1430 • 2012 ACR/ARHP Annual Meeting
Women with Systemic Lupus Erythematosus (SLE) May Have Different Predictors of Risk for Progression of Coronary Artery Calcium (CAC)Than Women without SLE
Background/Purpose: Women with SLE have increased rates of subclinical atherosclerosis and cardiovascular (CV) events. We sought to determine which risk factors may be significant in…Abstract Number: 1431 • 2012 ACR/ARHP Annual Meeting
Single Photon Emission Computed Tomography Contributes to Clinical Assessments in Neuropsychiatric Systemic Lupus Erythematosus Patients
Background/Purpose: Because the clinical manifestations of NPSLE are diverse, multifaceted approaches are necessary to evaluate the disease activity and therapeutic responses. We investigated contribution of…Abstract Number: 1432 • 2012 ACR/ARHP Annual Meeting
Safety and Efficacy of Etanercept in Systemic LUPUS Erythematosus
Background/Purpose: TNF is a strong mediator of inflammation with a controversial role in SLE. Whereas few open-label studies have shown efficacy of anti-TNFα agents in…Abstract Number: 1433 • 2012 ACR/ARHP Annual Meeting
Persistent Dyslipidemia Is a Risk Factor of Progression to Chronic Kidney Disease in Patients with Lupus Nephritis
Background/Purpose: To investigate the effect of dyslipidemia at baseline and during follow-up period on the progression to chronic kidney disease (CKD) in patients with biopsy-proven…Abstract Number: 1434 • 2012 ACR/ARHP Annual Meeting
Cardiovascular Morbidity in a Long-Term Follow-up Cohort of Systemic Lupus Erythematosus Patients in Southern Sweden
Background/Purpose: The main objective was to study the incidence of myocardial infarction in a cohort of patients with Systemic Lupus Erythematosus (SLE) assembled prospectively over…Abstract Number: 1435 • 2012 ACR/ARHP Annual Meeting
Identifying Systemic Lupus Erythematosus Patients At Higher Risk of Coronary Artery Disease
Background/Purpose: There is a high prevalence of premature atherosclerosis among patients with SLE. The traditional Framingham risk score (FRS) identifies few of the SLE patients…Abstract Number: 1396 • 2012 ACR/ARHP Annual Meeting
Associates of a History of Thrombosis in Systemic Lupus Erythematosus
Background/Purpose: Thrombosis in SLE is highly associated with antiphospholipid antibodies, yet the majority of those with antiphospholipid antibodies never have a thrombotic event. Plasma microparticles…Abstract Number: 1397 • 2012 ACR/ARHP Annual Meeting
Risk Factors Associated with Early Central Nervous System Damage Detected Through Perfusion MRI in Patients with Systemic Lupus Erythematosus
Background/Purpose: Antiphospholipid antibodies (aPL), hypertension and accumulated damage (SLICC-DI) have been associated to the severity of cerebral MRI lesions and to cognitive deficits in SLE.…Abstract Number: 1398 • 2012 ACR/ARHP Annual Meeting
Inflammatory Back Pain Is Increased in SLE and Associated with Anti-Sm Antibodies
Background/Purpose: Growing evidence suggest that autoantibodies may present in patients with ankylosing spondylitis. Here, we aim to determine the association of inflammatory back pain and…Abstract Number: 1399 • 2012 ACR/ARHP Annual Meeting
Regional Fat Distribution Is Independently Associated with Damage Accrual in Systemic Lupus Erythematosus Female Patients
Background/Purpose: In general population, a higher trunk fat and the ratio of trunk fat to leg fat (trunk-leg ratio) increase the risk for a cardiovascular…
ACR Meeting Abstracts